Plain-English translation of NCT07589608 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing two new injectable medications called and to see if they can help people with overweight or obesity lose weight. Some participants will receive one medication, some will receive both together, and some will receive a placebo (a dummy injection with no active ingredient) to compare results. The study will last about 64 weeks, or roughly 15 months.
Current weight management options don't work well enough for everyone, and researchers want to develop new treatments that are more effective at helping people lose weight and keep it off.
You likely qualify if…
You likely don't qualify if…
You will receive injections under your skin either once a week or at another scheduled interval over the 64-week study period. You'll visit the research clinic regularly for check-ups, blood tests, and weight measurements to track how the medication is working and monitor for any side effects. Roughly half the participants will receive the active medication(s) and half will receive placebo, though researchers will not tell you which group you're in until the study ends.
AI-generated summary from trial data · Jun 28, 2026 · Not medical advice
United States